Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment

MLA

Alice Newey, et al. “Immunopeptidomics of Colorectal Cancer Organoids Reveals a Sparse HLA Class I Neoantigen Landscape and No Increase in Neoantigens with Interferon or MEK-Inhibitor Treatment.” Journal for ImmunoTherapy of Cancer, vol. 7, no. 1, Nov. 2019, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s40425-019-0769-8.

APA

Alice Newey, Beatrice Griffiths, Justine Michaux, Hui Song Pak, Brian J. Stevenson, Andrew Woolston, Maria Semiannikova, Georgia Spain, Louise J. Barber, Nik Matthews, Sheela Rao, David Watkins, Ian Chau, George Coukos, Julien Racle, David Gfeller, Naureen Starling, David Cunningham, Michal Bassani-Sternberg, & Marco Gerlinger. (2019). Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. Journal for ImmunoTherapy of Cancer, 7(1), 1–15. https://doi.org/10.1186/s40425-019-0769-8

Chicago

Alice Newey, Beatrice Griffiths, Justine Michaux, Hui Song Pak, Brian J. Stevenson, Andrew Woolston, Maria Semiannikova, et al. 2019. “Immunopeptidomics of Colorectal Cancer Organoids Reveals a Sparse HLA Class I Neoantigen Landscape and No Increase in Neoantigens with Interferon or MEK-Inhibitor Treatment.” Journal for ImmunoTherapy of Cancer 7 (1): 1–15. doi:10.1186/s40425-019-0769-8.